

102000003974 Fibroblast Growth Factor 2 Human genes 0.000 claims description 267.108090000379 Fibroblast Growth Factor 2 Proteins 0.000 claims description 267.208000009745 Eye Disease Diseases 0.000 claims abstract description 18.201000011510 cancer Diseases 0.000 claims abstract description 43.150000001875 compounds Chemical class 0.000 claims abstract description 63.230000002401 inhibitory effect Effects 0.000 claims abstract description 101.239000005557 antagonist Substances 0.000 title claims description 118.230000003042 antagnostic Effects 0.000 title claims description 118.230000001575 pathological Effects 0.000 title claims abstract description 33.230000035168 lymphangiogenesis Effects 0.000 title claims abstract description 90.Assignors: BIKFALVI, ANDREAS Publication of US20150246118A1 publication Critical patent/US20150246118A1/en Status Abandoned legal-status Critical Current Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from EP12306330.7 external-priority Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Universite des Sciences et Tech (Bordeaux 1) filed Critical Institut National de la Sante et de la Recherche Medicale INSERM Assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE BORDEAUX I reassignment INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Institut National de la Sante et de la Recherche Medicale INSERM Universite des Sciences et Tech (Bordeaux 1) Priority date (The priority date is an assumption and is not a legal conclusion. Universite des Sciences et Tech (Bordeaux 1) Institut National de la Sante et de la Recherche Medicale INSERM Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US14/438,465 Inventor Andreas Bikfalvi Current Assignee (The listed assignees may be inaccurate.
Pathological condition lle pdf#
Google Patents Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesisĭownload PDF Info Publication number US20150246118A1 US20150246118A1 US14/438,465 US201314438465A US2015246118A1 US 20150246118 A1 US20150246118 A1 US 20150246118A1 US 201314438465 A US201314438465 A US 201314438465A US 2015246118 A1 US2015246118 A1 US 2015246118A1 Authority US United States Prior art keywords lyve fgf2 antagonist polypeptide cells Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20150246118A1 - Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesis
Pathological condition lle full#
View full terms and conditions of offer here.
Pathological condition lle mac#
Only one Promotion Product per eligible Mac or eligible iPad per Qualified Purchaser. Qualified Purchasers receive an Apple Gift Card when they purchase an eligible Mac or iPad at a Qualifying Location.
